v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Balance at beginning of period (in shares) at Dec. 31, 2024   606,388      
Balance at beginning of period at Dec. 31, 2024 $ 280,320 $ 606 $ 2,051,794 $ (1,772,341) $ 261
Increase (Decrease) in Stockholders' Equity          
Net loss (19,835)     (19,835)  
Other comprehensive loss 55       55
Foreign currency translation adjustment (12)       (12)
Exercise of pre-funded warrant (in shares)   30,370      
Exercise of pre-funded warrant 31 $ 31      
Issuance of common stock under equity plans (in shares)   155      
Issuances of common stock under equity plans 256   256    
Stock-based compensation related to issuances of common stock and options for services (in shares)   5      
Stock-based compensation related to issuances of common stock and options for services 15   15    
Stock-based compensation for equity-based awards to employees and directors 7,408   7,408    
Balance at end of period (in shares) at Mar. 31, 2025   636,918      
Balance at end of period at Mar. 31, 2025 268,238 $ 637 2,059,473 (1,792,176) 304
Balance at beginning of period (in shares) at Dec. 31, 2025   639,856      
Balance at beginning of period at Dec. 31, 2025 225,872 $ 640 2,080,804 (1,855,841) 269
Increase (Decrease) in Stockholders' Equity          
Net loss (3,642)     (3,642)  
Other comprehensive loss (412)       (412)
Foreign currency translation adjustment (48)       (48)
Issuance of common stock in connection with exercise of warrants 1,511   1,511    
Issuance of common stock under equity plans (in shares)   1,172      
Issuances of common stock under equity plans 914 $ 1 913    
Stock-based compensation related to issuances of common stock and options for services (in shares)   5      
Stock-based compensation related to issuances of common stock and options for services 13   13    
Stock-based compensation for equity-based awards to employees and directors 4,900   4,900    
Balance at end of period (in shares) at Mar. 31, 2026   641,033      
Balance at end of period at Mar. 31, 2026 $ 229,108 $ 641 $ 2,088,141 $ (1,859,483) $ (191)